COVID-19

Battling COVID-19: Human trials for novel coronavirus vaccine begin at UK

As the world races to develop a vaccine against the coronavirus, researchers working at the Imperial College of London have started human trials for a new coronavirus vaccine. The UK government has allotted £41 million for developing the vaccine and an additional £5m is gathered through philanthropic donations.

According to Professor Robin Shattock, from the Department of Infectious Disease at Imperial, “The COVID-19 outbreak has claimed several lives and had a huge impact on daily life. In the long-term, a viable vaccine could be vital for protecting the most vulnerable, enabling restrictions to be eased and helping people to get back to normal life.”

The vaccine for COVID-19 is based on RNA technology, offering genetic signals to build the “spike” protein on the top of the coronavirus surface. Once injected inside the muscle, the RNA multiply the copies of itself and instructs the body cells to make various copies of a spiky protein found on the surface of the virus. This is effective in boosting the immunity and preventing the body against the infection of COVID-19 in future. The vaccine samples proved effective in animal studies. Two vaccine doses would be offered to 300 healthy volunteers in the upcoming weeks. If the vaccine comes out to be effective and emerges as a good immune response in humans, the researchers will begin the next phase of trials on a large level with over 6,000 healthy volunteers.

Earlier, the researchers planned to set up a special company for better access to poor countries once the vaccine is developed. VacEquity Global Health (VGH), a venture is set up by the Imperial College and Hong Kong-based Morningside Ventures for distributing the vaccine worldwide.

Recently, Oxford University has initiated an advanced study with over 10,000 volunteers for it. The US is also planning to ambush the next month with around 30,000 volunteers testing different vaccines on candidates.

Daniel is our UK-based freelance Editor. As part of our quest towards credible news, Doctor's Clinic Blog India affiliates with individuals from other parts of the world to provide an in-depth focus on essential topics. Daniel received his degree from the University of Sheffield, and since then, worked to multiple sites as a freelance contributor and editor.

Daniel Martin

Daniel is our UK-based freelance Editor. As part of our quest towards credible news, Doctor's Clinic Blog India affiliates with individuals from other parts of the world to provide an in-depth focus on essential topics. Daniel received his degree from the University of Sheffield, and since then, worked to multiple sites as a freelance contributor and editor.

Share
Published by
Daniel Martin

Recent Posts

Remidio Changing the eye care industry with its Mobile retinal imaging device

The five senses are dominated by vision, which is essential to every aspect of our…

2 months ago

Palak Tiwari’s fitness secret revealed: All you need to know

It is true when dieticians and nutritionists say, ‘You are what you eat’. Just ask…

5 months ago

Oncology Billing 101: All you need to know

Cancer is a debilitating disease responsible for nearly 10 million deaths in 2020. For perspective,…

5 months ago

A quick guide to understanding the difference between liver and kidney

Even a sixth grader can recount the difference between the liver and kidney. However, not…

6 months ago

Vipassana Sets You Free, But You Must Have The Will To Survive The First 10 Days

Rajat Khare, a well-known entrepreneur and the creator of the Luxembourg-based investment fund Boundary Holding,…

6 months ago

Fitness mantras for a healthy mind and body (post pandemic)

The Covid-19 pandemic has changed the ways to remain fit with the focus on both…

7 months ago